Niacin As Secondary Prevention Of Coronary Artery Disease (NASPOCAD)
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Aim of the study is to show additional effects of the combined therapy of niacin and statins
analyzing number and function of EPCs and other stem cell populations and adiponectin as well
as hsCRP levels in patients with CAD.